Back
Disc Medicine Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Buy
66
IRON
Disc Medicine
Last Price:
30.30
Seasonality Move:
-1.8%
Sell
14
AMLX
Amylyx Pharmaceuticals
Last Price:
1.76
Seasonality Move:
101.62%
Buy
66
Disc Medicine (IRON)
is a Buy
Is Disc Medicine a Buy, Sell or Hold?
- The current Disc Medicine [IRON] share price is $30.36. The Score for IRON is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- IRON is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
14
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.76. The Score for AMLX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IRON Stock Price Chart
What is Disc Medicine's stock price today?
-
The Disc Medicine share price today is $30.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRON is experiencing slight selling pressure.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.
IRON Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.13 | Sell |
Relative Strength Index (14 RSI): | 39.58 | Sell |
Chaikin Money Flow: | -1112 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.86 - 31.18) | Buy |
Bollinger Bands (100): | (37.74 - 69.74) | Sell |
AMLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 25.39 | Sell |
Chaikin Money Flow: | -1523096 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.79 - 2.27) | Sell |
Bollinger Bands (100): | (3.04 - 16.76) | Sell |
IRON Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.73 | Buy |
20-day SMA: | 28.94 | Buy |
50-day SMA: | 43.79 | Sell |
200-day SMA: | 52.23 | Sell |
8-day EMA: | 29.76 | Buy |
20-day EMA: | 31.12 | Sell |
50-day EMA: | 39.86 | Sell |
200-day EMA: | 47.78 | Sell |
AMLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.94 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 4.09 | Sell |
200-day SMA: | 13.92 | Sell |
8-day EMA: | 1.9 | Sell |
20-day EMA: | 2.17 | Sell |
50-day EMA: | 4.59 | Sell |
200-day EMA: | 12.93 | Sell |
Disc Medicine Earnings Growth & IRON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, an increase next quarter of $0.06 per share, a decrease this year of $1.50 per share, and a decrease next year of $0.28 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.04 per share, an increase next quarter of $0.18 per share, a decrease this year of $2.79 per share, and an increase next year of $0.45 per share.
Disc Medicine Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amylyx Pharmaceuticals Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |